CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Lewis William Chair and CEO | Sale 10b5-1 | −3,723 | $104.28 | $388K | 262,665 |
| 2026-06-25 | Lewis William Chair and CEO | Sale 10b5-1 | −2,456 | $105.27 | $259K | 260,209 |
| 2026-06-25 | Lewis William Chair and CEO | Sale 10b5-1 | −1,292 | $106.27 | $137K | 258,917 |
| 2026-06-25 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −12,518 | 12,519 | ||
| 2026-06-25 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,880 | 8,880 | ||
| 2026-06-23 | Butera Samuele SVP, GM, Global Respiratory | Grant or award | +7,342 | 7,342 | ||
| 2026-06-23 | Butera Samuele SVP, GM, Global Respiratory | Grant or award · Stock Option (right to buy) | +12,570 | 12,570 | ||
| 2026-06-22 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −1,806 | $95.82 | $173K | 37,648 |
| 2026-06-08 | Lewis William Chair and CEO | Sale 10b5-1 | −6,515 | $94.03 | $613K | 258,917 |
| 2026-06-05 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,858 | $103.78 | $193K | 60,486 |
| 2026-06-03 | Smith Michael Alexander Chief Legal Officer | Sale | −2,159 | $102.27 | $221K | 39,454 |
| 2026-06-03 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −2,566 | $102.27 | $262K | 62,344 |
| 2026-06-03 | Adsett Roger Chief Operating Officer | Sale | −2,370 | $102.27 | $242K | 98,603 |
| 2026-06-03 | Bonstein Sara Chief Financial Officer | Sale | −2,404 | $102.27 | $246K | 69,082 |
| 2026-06-03 | Lewis William Chair and CEO | Sale | −7,605 | $102.27 | $778K | 265,432 |
| 2026-05-22 | Smith Michael Alexander Chief Legal Officer | Sale 10b5-1 | −6,149 | $108.47 | $667K | 41,613 |
| 2026-05-18 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 294,161 |
| 2026-05-18 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 298,601 |
| 2026-05-18 | Lewis William Chair and CEO | Sale 10b5-1 | −5,753 | $105.32 | $606K | 292,848 |
| 2026-05-18 | Lewis William Chair and CEO | Sale 10b5-1 | −11,836 | $106.39 | $1.3M | 281,012 |
Page 3 of 23 · 448 trades